血小板数の増加は,女性の性別と喘息の重症度に関連しています
Neha Solanki1,2, Battoul Fakhry3, Amy Attaway1,2
1Integrated Hospital Care Institute, Cleveland Clinic, Cleveland, Ohio.
The journal of allergy and clinical immunology. Global
|September 2, 2025
まとめ
女性の喘息患者では血小板数が高く,喘息の重症度が増加します. 血小板数は喘息のバイオマーカーとして機能し,性別の炎症効果があります.
科学分野:
- 肺医学
- 血液学
- 免疫学
背景:
- 喘息は生涯にわたって 性別による顕著な違いを示します
- 血小板の活性化はステロイド耐性喘息に関連しています.
- 喘息の罹患率と重症度における 性差はよく記録されています
研究 の 目的:
- 女性における血小板数の増加は,男性と比較して喘息の罹患率と重症度の増加と相関しているという仮説を検証する.
- 性別による血小板数と 喘息の重症性の関連を調べる
主な方法:
- UK Biobank 参加者のベースラインデータを横断分析した.
- 年齢,BMI,性別,人種,喫煙状況,C反応性タンパク質,絶対エオシノフィルと中性粒子の数を含む共変数で調整された二項多変数ロジスティック回帰.
- 血小板数は男女間比較され,喘息の重度と炎症マーカーと相関しました.
主要な成果:
- 女性の性別は,喘息患者と非喘息患者の両方の血小板数が高かった.
- 喘息の女性は,喘息の男性よりも血小板の中央値 (30 × 10^3/μL) が有意に高かった.
- 喘息患者における血小板数の増加は,喘息の重症度およびC反応性タンパク質のレベル,絶対エオシノフィルの数,および絶対中性粒子の数値の上昇と相関していた.
結論:
- 血小板数は両性において喘息と炎症に関連しており,喘息の重度のバイオマーカーとしての可能性を示唆しています.
- 血小板数の男女間の差異的な影響は,さらなる調査が必要である.
- 将来の研究は,性ホルモン,血小板活性化,喘息の重症度との相互作用を,メカニズム的研究によって探求すべきである.
関連する概念動画
01:29Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
01:26Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
01:20Asthma: Pathogenesis and Management
576
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
576
01:24Asthma-III: Symptoms and Complications
2.6K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.6K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
644
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
644
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K